Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma.

Ozan Cem Guler,Ezgi Oymak,Pervin Hurmuz,Guler Yavas,Burak Tilki,Cagdas Yavas,Gokhan Ozyigit,Cem Onal

Urologia internationalis（2023）

引用 0|浏览9

暂无评分

摘要

SBRT is a successful treatment for oligometastatic RCC patients due to its excellent LC and minimal toxicity profile. There were no statistically significant survival differences between patients with synchronous and metachronous oligometastasis. Patients with solitary oligometastasis outlived their counterparts.

查看译文

关键词

Oligometastasis,Radiotherapy,Renal cell carcinoma,Stereotactic body radiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要